Company: LIFD
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001096906-25-000819
Chunk: 66

Company: LFTD PARTNERS INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 66
---
 by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is calculated by dividing earnings (loss) by the weighted-average number of common shares and dilutive common share equivalents outstanding during the period. When dilutive, the incremental potential common shares issuable upon exercise of stock options and warrants are determined by the treasury stock method. The following table summarizes the calculations of basic and diluted earnings (loss) per common share for the quarters ended March 31, 2025 and 2024:   For the Three Months Ended   March 31,   2025  2024 Net Loss $(303,042) $(1,141,004)         Weighted average number of common shares outstanding:        Basic  14,822,678   14,805,678 Diluted  14,822,678   14,805,678          Basic Net Loss per Common Share $(0.02) $(0.08)Diluted Net Loss per Common Share $(0.02) $(0.08)

 F-43Table of Contents

 As of March 31, 2025, the Company did not have any options or warrants outstanding. However, as of March 31, 2025, the Company did have outstanding 2,500 shares of Series A Preferred Stock convertible into 250,000 shares of common stock; these are not included in the diluted earnings calculation.  As of March 31, 2025, the Company also had 40,000 shares of Series B Preferred Stock outstanding convertible into 40,000 shares of common stock; these are not included in the diluted earnings calculation. There were also 142,000 shares of Deferred Contingent Stock, issuable upon instruction by the respective Deferred Contingent Stock Recipients, included in the March 31, 2025 diluted EPS calculation. As of March 31, 2024, in addition to our outstanding common stock, we had issued (a) options to purchase 1,076,698 shares of common stock at $2.00 per share, (b) warrants to purchase 155,500 shares of common stock at $1.00 per share, (c) rights to purchase warrants to purchase 100,000 shares of common stock at $1.85 per share, and (d) warrants to purchase 2,280,000 shares of